impact factor
logo
 

Letter

 

Unilateral generalised morphea successfully treated with rituximab and mycophenolate mofetil


1, 2, 3, 4, 5, 6

 

  1. Department of Health Science, Section of Dermatology, USL Toscana Centro, Rare Diseases Unit, European Reference Network-Skin Member, University of Florence, Italy.
  2. Department of Health Science, Section of Dermatology, USL Toscana Centro, Rare Diseases Unit, European Reference Network-Skin Member, University of Florence, Italy.
  3. Department of Health Science, Section of Dermatology, USL Toscana Centro, Rare Diseases Unit, European Reference Network-Skin Member, University of Florence, Italy.
  4. Division of Pathological Anatomy, Department of Health Sciences, University of Florence, Italy.
  5. Rheumatology Unit, Ospedale San Giovanni di Dio, Florence, Italy.
  6. Department of Health Science, Section of Dermatology, USL Toscana Centro, Rare Diseases Unit, European Reference Network-Skin Member, University of Florence, Italy.

CER14267
Letter

Free to view
(click on article PDF icon to read the article)

PMID: 33822702 [PubMed]

Received: 25/11/2020
Accepted : 14/01/2021
In Press: 30/03/2021

Rheumatology Article